Matt Thums, a wheelchair curler from Wisconsin, concluded his second Paralympic appearance in Cortina, Italy, this week.
Phase 3 MajesTEC-3 trial data demonstrate significant improvements in both progression free survival and overall survival with teclistamab plus daratumumab hyaluronidase-fihj. The approval was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results